<p><em>大猩猩® 踝关节融合板系统推出，适用于复杂踝关节融合</em></p>
<p><em>幻影® TTC 创伤钉增强复杂后足损伤的治疗选择</em></p>
<p>, /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE 和 SIX: ZBH)，全球医疗技术领导者，以及其全资子公司 Paragon 28，今天宣布全面商业推出两种创新解决方案，旨在为复杂的足部和踝关节创伤提供外科医生先进的工具，以精确和高效地处理挑战性的踝关节骨折和后足损伤。</p>
<p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/1603977/Zimmer_Biomet_Holdings_Logo.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/1603977/Zimmer_Biomet_Holdings_Logo.jpg"/></p>
<p>大猩猩® 踝关节融合板系统和幻影® TTC 创伤钉的推出标志着 Zimmer Biomet 足部和踝关节创伤产品组合的重要扩展。</p>
<p>&#34;这两款产品的推出强调了 Zimmer Biomet 致力于开发创新，以帮助外科医生安全高效地解决复杂临床问题的承诺，&#34; Zimmer Biomet 足部和踝关节全球总裁 Albert DaCosta 说。&#34;通过将这些新解决方案推向市场，我们可以为医生提供额外的技术，以应对历史上几乎没有可靠选择的患者群体。&#34;</p>
<p><em>大猩猩踝关节融合板系统</em></p>
<p>大猩猩踝关节融合板系统为患有踝关节骨折的患者提供了初级胫距关节融合的解决方案。踝关节骨折约占所有胫骨骨折的 7% 到 10%，其中一小部分但临床上显著的患者因严重粉碎或关节面丧失而需要进行初级踝关节融合。1</p>
<p>该系统与领先的骨科创伤足部和踝关节外科医生合作开发，提供可靠的双柱固定，适用于严重或愈合不良的胫骨踝关节骨折。其解剖轮廓板、精密工程仪器和简化的工作流程使得在单次手术中实现稳定固定和融合成为可能。双板结构——提供多种长度——具有轮廓化的前外侧和内侧选项，优化了开放和经皮方法。II 型阳极氧化板在生物力学上经过工程设计，具有区域特定的厚度和锥形末端，以减少软组织损伤。其他特点包括先进的经皮导向器、跨越干骺端粉碎的长轴板设计和全面的关节准备仪器。</p>
<p>&#34;这是市场上第二款专门为粉碎性踝关节骨折的初级踝关节融合设计的板，&#34; 田纳西州孟菲斯的 Campbell Clinic 医院骨科主任 Clayton Bettin 医生说。&#34;大猩猩踝关节融合系统提供了一种低轮廓选项，具有解剖轮廓，能够在两个柱之间实现稳定固定。这是治疗这些否则会造成严重伤害的重大进步。&#34;</p>
<p><em>幻影 TTC 创伤钉</em> 在经过验证的幻影® TTC 钉平台基础上，幻影 TTC 创伤钉提供扩展的长度（150 mm、300 mm 和 350 mm）和固定能力，以处理更具挑战性的创伤病例，包括需要胫距跟骨融合的复杂踝关节骨折。</p>
<p>&#34;这款新钉让我能够利用我在选择性病例中使用的同一可信赖的幻影平台，现在适用于创伤指征，&#34; Cedars-Sinai 医疗中心的足部和踝关节骨科医生 Max Michalski 医生说。</p>
<p>幻影 TTC 创伤钉的主要特点包括：</p>
<ul>
<li><strong>PRECISION® 导向技术</strong>，确保钉子放置的一致性和准确性</li>
<li><strong>集成内部压缩机制</strong>，提供高达 8 mm 的可控压缩</li>
<li><strong>先进的螺纹钉选项</strong>，直径为 Ø7.2 mm 和 Ø5.0 mm，具有多种定位配置</li>
<li><strong>左右特定配置</strong> 和直径（Ø10.0、Ø11.5、Ø13.0 mm），以实现量身定制的固定</li>
</ul>
<p>大猩猩踝关节融合板系统和幻影 TTC 创伤钉目前可供美国足部和踝关节专家使用。</p>
<p><strong>关于 Zimmer Biomet</strong> Zimmer Biomet 是一家全球医疗技术领导者，拥有全面的产品组合，旨在最大化移动性并改善健康。我们通过创新产品和一系列集成的数字和机器人技术，利用数据、数据分析和人工智能，顺畅地转变患者体验。</p>
<p>凭借 90 多年的可信领导和证明的专业知识，Zimmer Biomet 准备为患者和提供者提供最高质量的解决方案。我们的遗产今天继续通过我们不断进化和创新的文化得以体现。</p>
<p>有关我们产品组合、在 25 个以上国家的运营和在 100 个以上国家的销售或加入我们团队的更多信息，请访问 www.zimmerbiomet.com 或在 LinkedIn 上关注 www.linkedin.com/company/zimmerbiomet 或在 X 上关注 www.x.com/zimmerbiomet。</p>
<p><strong>关于前瞻性声明的警示性声明</strong> 本新闻稿包含根据 1995 年《私人证券诉讼改革法案》的安全港条款定义的前瞻性声明。前瞻性声明包括但不限于关于 Zimmer Biomet 的期望、计划、前景以及产品和服务提供的声明，包括新产品发布和潜在的临床成功。这些声明基于管理层当前的信念和期望，并受到重大风险、不确定性和情况变化的影响，这可能导致实际结果与预期结果存在重大差异。有关这些风险和不确定性的列表和描述，请参见 Zimmer Biomet 向美国证券交易委员会（SEC）提交的定期报告。这些因素不应被视为详尽无遗，并应与 Zimmer Biomet 在 SEC 提交的其他警示性声明一起阅读。前瞻性声明仅在作出之日有效，Zimmer Biomet 不承担更新或修订任何前瞻性声明的意图或义务，无论是由于新信息、未来事件还是其他原因。本新闻稿的读者应谨慎对待这些前瞻性声明，因为无法保证这些前瞻性声明将被证明是准确的。此警示性声明适用于本新闻稿中包含的所有前瞻性声明。</p>
<table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>联系人：</strong><br/><strong>媒体</strong><br/>Troy Kirkpatrick<br/>614-284-1926<br/>troy.kirkpatrick@zimmerbiomet.com <br/>Kirsten Fallon<br/>781-779-5561<br/>kirsten.fallon@zimmerbiomet.com</td>
<td><strong>投资者</strong><br/>David DeMartino<br/>646-531-6115<br/>david.demartino@zimmerbiomet.com <br/>Zach Weiner<br/>908-591-6955<br/>zach.weiner@zimmerbiomet.com</td>
</tr>
</tbody>
</table>
<table>
<thead>
<tr>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>\<em>\</em>\______________________</td>
</tr>
<tr>
<td>1 Mauffrey, C., Vasario, G., Battiston, B., Lewis, C., Beazley, J., &amp; Seligson, D. (2011). 胫骨踝部骨折：发生率、诊断、治疗和并发症的回顾。比利时骨科杂志，77(4)，432–440。</td>
</tr>
</tbody>
</table>
<p>来源：Zimmer Biomet Holdings, Inc.</p>

<p>Zimmer Biomet Holdings, Inc. 推出了两种针对复杂足踝创伤的新解决方案：Gorilla® Pilon 融合固定系统和 Phantom® TTC 创伤钉。这些创新旨在为外科医生提供先进的工具，以治疗具有挑战性的胫骨骨折和后足损伤。Gorilla 系统为主要的踝关节融合提供可靠的固定，而 Phantom 钉则扩展了复杂病例的治疗选择。这两款产品现已面向美国的足踝专家提供，反映了 Zimmer Biomet 在医疗技术领域提升外科解决方案的承诺</p>

<p><em>Gorilla® Pilon Fusion Plating System Introduced for Complex Ankle Fusions</em></p>
<div class="lb-trans"><p><em>大猩猩® 踝关节融合板系统推出，适用于复杂踝关节融合</em></p>
</div><p><em>Phantom® TTC Trauma Nail Enhances Treatment Options for Complex Hindfoot Injuries</em></p>
<div class="lb-trans"><p><em>幻影® TTC 创伤钉增强复杂后足损伤的治疗选择</em></p>
</div><p>, /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, and Paragon 28, a wholly owned subsidiary, today announced the full commercial launch of two innovative solutions for complex foot and ankle trauma to offer surgeons advanced tools to address challenging pilon fractures and hindfoot injuries with precision and efficiency.</p>
<div class="lb-trans"><p>, /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE 和 SIX: ZBH)，全球医疗技术领导者，以及其全资子公司 Paragon 28，今天宣布全面商业推出两种创新解决方案，旨在为复杂的足部和踝关节创伤提供外科医生先进的工具，以精确和高效地处理挑战性的踝关节骨折和后足损伤。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://mma.prnewswire.com/media/1603977/Zimmer_Biomet_Holdings_Logo.jpg" alt="" original-src="https://mma.prnewswire.com/media/1603977/Zimmer_Biomet_Holdings_Logo.jpg"/></p>
<p>The launches of the Gorilla® Pilon Fusion Plating System and the Phantom® TTC Trauma Nail mark a significant expansion of Zimmer Biomet's foot and ankle trauma portfolio.</p>
<div class="lb-trans"><p>大猩猩® 踝关节融合板系统和幻影® TTC 创伤钉的推出标志着 Zimmer Biomet 足部和踝关节创伤产品组合的重要扩展。</p>
</div><p>&#34;The launches of these two products underscore Zimmer Biomet's commitment to developing innovations that help surgeons safely and efficiently address complex clinical problems,&#34; said Albert DaCosta, Global President Foot and Ankle, Zimmer Biomet. &#34;By bringing these new solutions to market, we can offer physicians additional technologies to address patient populations that have historically had few reliable options.&#34;</p>
<div class="lb-trans"><p>&#34;这两款产品的推出强调了 Zimmer Biomet 致力于开发创新，以帮助外科医生安全高效地解决复杂临床问题的承诺，&#34; Zimmer Biomet 足部和踝关节全球总裁 Albert DaCosta 说。&#34;通过将这些新解决方案推向市场，我们可以为医生提供额外的技术，以应对历史上几乎没有可靠选择的患者群体。&#34;</p>
</div><p><em>The Gorilla Pilon Fusion Plating System</em></p>
<div class="lb-trans"><p><em>大猩猩踝关节融合板系统</em></p>
</div><p>The Gorilla Pilon Fusion Plating System offers a solution for primary tibiotalar fusion in patients with pilon fractures. Pilon fractures account for approximately7% to 10% of all tibial fractures <strong>,</strong> with asmall but clinically significant group of patients requiring primary ankle fusion due to severe comminution or articular surface loss.1</p>
<div class="lb-trans"><p>大猩猩踝关节融合板系统为患有踝关节骨折的患者提供了初级胫距关节融合的解决方案。踝关节骨折约占所有胫骨骨折的 7% 到 10%，其中一小部分但临床上显著的患者因严重粉碎或关节面丧失而需要进行初级踝关节融合。1</p>
</div><p>Developed in collaboration with leading orthopedic trauma foot and ankle surgeons, the system delivers reliable dual-column fixation for severe or malunited tibial pilon fractures. Its anatomically-contoured plates, precision-engineered instrumentation, and streamlined workflow enable stable fixation and fusion in a single procedure. Dual-plating constructs — available in various lengths — feature contoured anterolateral and medial options, optimized for both open and percutaneous approaches. Type II anodized plates are biomechanically engineered with region-specific thickness and tapered ends to reduce soft tissue disruption. Additional features include advanced percutaneous guides, long-shaft plate designs to span metaphyseal comminution and comprehensive joint preparation instrumentation.</p>
<div class="lb-trans"><p>该系统与领先的骨科创伤足部和踝关节外科医生合作开发，提供可靠的双柱固定，适用于严重或愈合不良的胫骨踝关节骨折。其解剖轮廓板、精密工程仪器和简化的工作流程使得在单次手术中实现稳定固定和融合成为可能。双板结构——提供多种长度——具有轮廓化的前外侧和内侧选项，优化了开放和经皮方法。II 型阳极氧化板在生物力学上经过工程设计，具有区域特定的厚度和锥形末端，以减少软组织损伤。其他特点包括先进的经皮导向器、跨越干骺端粉碎的长轴板设计和全面的关节准备仪器。</p>
</div><p>&#34;This is only the second plate on the market specifically designed for primary ankle fusion in the setting of comminuted pilon fractures,&#34; said Dr. Clayton Bettin, Division Chief of Hospital Orthopedics at Campbell Clinic in Memphis, Tenn. &#34;The Gorilla Pilon Fusion System offers a lower-profile option that is anatomically contoured and enables stable fixation across both columns. It's a major step forward in treating these otherwise devastating injuries.&#34;</p>
<div class="lb-trans"><p>&#34;这是市场上第二款专门为粉碎性踝关节骨折的初级踝关节融合设计的板，&#34; 田纳西州孟菲斯的 Campbell Clinic 医院骨科主任 Clayton Bettin 医生说。&#34;大猩猩踝关节融合系统提供了一种低轮廓选项，具有解剖轮廓，能够在两个柱之间实现稳定固定。这是治疗这些否则会造成严重伤害的重大进步。&#34;</p>
</div><p><em>The PhantomTTC Trauma Nail</em> Building on the proven Phantom® TTC Nail platform, the Phantom TTC Trauma Nail provides expanded lengths (150 mm, 300 mm, and 350 mm) and fixation capabilities to manage more demanding trauma cases, including complex pilon fractures requiring tibiotalocalcaneal fusion.</p>
<div class="lb-trans"><p><em>幻影 TTC 创伤钉</em> 在经过验证的幻影® TTC 钉平台基础上，幻影 TTC 创伤钉提供扩展的长度（150 mm、300 mm 和 350 mm）和固定能力，以处理更具挑战性的创伤病例，包括需要胫距跟骨融合的复杂踝关节骨折。</p>
</div><p>&#34;This new nail allows me to leverage the same trusted Phantom platform I use in elective cases, now adapted for trauma indications,&#34; saidDr. Max Michalski, Foot and Ankle orthopedic surgeon at Cedars-Sinai Medical Center.</p>
<div class="lb-trans"><p>&#34;这款新钉让我能够利用我在选择性病例中使用的同一可信赖的幻影平台，现在适用于创伤指征，&#34; Cedars-Sinai 医疗中心的足部和踝关节骨科医生 Max Michalski 医生说。</p>
</div><p>Key features of the Phantom TTC Trauma Nail include:</p>
<div class="lb-trans"><p>幻影 TTC 创伤钉的主要特点包括：</p>
</div><ul>
<li><strong>PRECISION® Guide Technology</strong> for consistent, accurate nail placement</li>
<li><strong>Integrated internal compression mechanism</strong> delivering up to 8 mm of controlled compression</li>
<li><strong>Advanced threaded peg options</strong> in Ø7.2 mm and Ø5.0 mm sizes with multiple targeting configurations</li>
<li><strong>Right and left-specific configurations</strong> and diameters (Ø10.0, Ø11.5, Ø13.0 mm) for tailored fixation</li>
</ul>
<div class="lb-trans"><ul>
<li><strong>PRECISION® 导向技术</strong>，确保钉子放置的一致性和准确性</li>
<li><strong>集成内部压缩机制</strong>，提供高达 8 mm 的可控压缩</li>
<li><strong>先进的螺纹钉选项</strong>，直径为 Ø7.2 mm 和 Ø5.0 mm，具有多种定位配置</li>
<li><strong>左右特定配置</strong> 和直径（Ø10.0、Ø11.5、Ø13.0 mm），以实现量身定制的固定</li>
</ul>
</div><p>Both the Gorilla Pilon Fusion Plating System and the Phantom TTC Trauma Nail are currently available for use by U.S.-based foot and ankle specialists.</p>
<div class="lb-trans"><p>大猩猩踝关节融合板系统和幻影 TTC 创伤钉目前可供美国足部和踝关节专家使用。</p>
</div><p><strong>About Zimmer Biomet</strong> Zimmer Biomet isaglobal medical technology leader with a comprehensive portfolio designed to maximize mobility and improve health.We seamlessly transform the patient experience through our innovative products and suite of integrated digital and robotic technologies that leverage data, data analytics and artificial intelligence.</p>
<div class="lb-trans"><p><strong>关于 Zimmer Biomet</strong> Zimmer Biomet 是一家全球医疗技术领导者，拥有全面的产品组合，旨在最大化移动性并改善健康。我们通过创新产品和一系列集成的数字和机器人技术，利用数据、数据分析和人工智能，顺畅地转变患者体验。</p>
</div><p>With 90+ years of trusted leadership and proven expertise, Zimmer Biomet is positioned to deliver the highest quality solutions to patients and providers.Our legacy continues to come to life today through our progressive culture of evolution and innovation.</p>
<div class="lb-trans"><p>凭借 90 多年的可信领导和证明的专业知识，Zimmer Biomet 准备为患者和提供者提供最高质量的解决方案。我们的遗产今天继续通过我们不断进化和创新的文化得以体现。</p>
</div><p>For more information about our product portfolio, our operations in 25+ countries and sales in 100+ countries or about joining our team, visit www.zimmerbiomet.comor follow on LinkedIn at www.linkedin.com/company/zimmerbiomet or X atwww.x.com/zimmerbiomet.</p>
<div class="lb-trans"><p>有关我们产品组合、在 25 个以上国家的运营和在 100 个以上国家的销售或加入我们团队的更多信息，请访问 www.zimmerbiomet.com 或在 LinkedIn 上关注 www.linkedin.com/company/zimmerbiomet 或在 X 上关注 www.x.com/zimmerbiomet。</p>
</div><p><strong>Cautionary Statement Regarding Forward-Looking Statements</strong> This news release contains forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, but are not limited to, statements concerning Zimmer Biomet's expectations, plans, prospects, and product and service offerings, including new product launches and potential clinical successes. Such statements are based upon the current beliefs and expectations of management and are subject to significant risks, uncertainties and changes in circumstances that could cause actual outcomes and results to differ materially. For a list and description of some of such risks and uncertainties, see Zimmer Biomet's periodic reports filed with theU.S.Securities and Exchange Commission (SEC). These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements that are included in Zimmer Biomet's filings with the SEC. Forward-looking statements speak only as of the date they are made, and Zimmer Biomet disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. Readers of this news release are cautioned not to rely on these forward-looking statements, since there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this news release.</p>
<div class="lb-trans"><p><strong>关于前瞻性声明的警示性声明</strong> 本新闻稿包含根据 1995 年《私人证券诉讼改革法案》的安全港条款定义的前瞻性声明。前瞻性声明包括但不限于关于 Zimmer Biomet 的期望、计划、前景以及产品和服务提供的声明，包括新产品发布和潜在的临床成功。这些声明基于管理层当前的信念和期望，并受到重大风险、不确定性和情况变化的影响，这可能导致实际结果与预期结果存在重大差异。有关这些风险和不确定性的列表和描述，请参见 Zimmer Biomet 向美国证券交易委员会（SEC）提交的定期报告。这些因素不应被视为详尽无遗，并应与 Zimmer Biomet 在 SEC 提交的其他警示性声明一起阅读。前瞻性声明仅在作出之日有效，Zimmer Biomet 不承担更新或修订任何前瞻性声明的意图或义务，无论是由于新信息、未来事件还是其他原因。本新闻稿的读者应谨慎对待这些前瞻性声明，因为无法保证这些前瞻性声明将被证明是准确的。此警示性声明适用于本新闻稿中包含的所有前瞻性声明。</p>
</div><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>Contacts:</strong><br/><strong>Media</strong><br/>Troy Kirkpatrick<br/>614-284-1926<br/>troy.kirkpatrick@zimmerbiomet.com <br/>Kirsten Fallon<br/>781-779-5561<br/>kirsten.fallon@zimmerbiomet.com</td>
<td><strong>Investors</strong><br/>David DeMartino<br/>646-531-6115<br/>david.demartino@zimmerbiomet.com <br/>Zach Weiner<br/>908-591-6955<br/>zach.weiner@zimmerbiomet.com</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>联系人：</strong><br/><strong>媒体</strong><br/>Troy Kirkpatrick<br/>614-284-1926<br/>troy.kirkpatrick@zimmerbiomet.com <br/>Kirsten Fallon<br/>781-779-5561<br/>kirsten.fallon@zimmerbiomet.com</td>
<td><strong>投资者</strong><br/>David DeMartino<br/>646-531-6115<br/>david.demartino@zimmerbiomet.com <br/>Zach Weiner<br/>908-591-6955<br/>zach.weiner@zimmerbiomet.com</td>
</tr>
</tbody>
</table>
</div><table>
<thead>
<tr>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>\<em>\</em>\______________________</td>
</tr>
<tr>
<td>1 Mauffrey, C., Vasario, G., Battiston, B., Lewis, C., Beazley, J., &amp; Seligson, D. (2011). Tibial pilon fractures: a review of incidence, diagnosis, treatment, and complications. Acta orthopaedica Belgica, 77(4), 432–440.</td>
</tr>
</tbody>
</table>
<div class="lb-trans"><table>
<thead>
<tr>
<th></th>
</tr>
</thead>
<tbody>
<tr>
<td>\<em>\</em>\______________________</td>
</tr>
<tr>
<td>1 Mauffrey, C., Vasario, G., Battiston, B., Lewis, C., Beazley, J., &amp; Seligson, D. (2011). 胫骨踝部骨折：发生率、诊断、治疗和并发症的回顾。比利时骨科杂志，77(4)，432–440。</td>
</tr>
</tbody>
</table>
</div><p>SOURCE Zimmer Biomet Holdings, Inc.</p>
<div class="lb-trans"><p>来源：Zimmer Biomet Holdings, Inc.</p>
</div>

Zimmer Biomet 推出两种新的足踝解决方案以应对复杂创伤病例 | ZBH 股票新闻